Vignette-based EQ-5D-5L study quantifying the quality-of-life burden from sleep disturbance and early-morning OFF symptoms in people with advancing Parkinson's disease.

Highlights clinically important, measurable symptomatic burdens that can guide outcome selection and symptomatic intervention priorities in trials, but offers little mechanistic or drug-discovery information.